USANA Health Sciences Insider Deborah Woo Sells 1,340 Shares (USNA)
USANA Health Sciences (NASDAQ:USNA) Insider Deborah Woo sold 1,340 shares of the stock in a transaction that occurred on Wednesday, September 11th. The stock was sold at an average price of $79.01, for a total value of $105,873.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
USNA has been the subject of a number of recent research reports. Analysts at Janney Montgomery Scott raised their price target on shares of USANA Health Sciences (NASDAQ:USNA) from $49.00 to $72.00 in a research note to investors on Thursday, July 25th. They now have a “neutral” rating on the stock. Separately, analysts at Canaccord Genuity raised their price target on shares of USANA Health Sciences (NASDAQ:USNA) from $54.00 to $75.00 in a research note to investors on Wednesday, July 24th. Finally, analysts at DA Davidson reiterated a “neutral” rating on shares of USANA Health Sciences (NASDAQ:USNA) in a research note to investors on Wednesday, July 24th. They now have a $92.00 price target on the stock, up previously from $80.00.
Four research analysts have rated the stock with a hold rating, The company currently has an average rating of “Hold” and an average price target of $74.28.
Shares of USANA Health Sciences (NASDAQ:USNA) traded up 1.05% on Wednesday, hitting $79.26. 77,218 shares of the company’s stock traded hands. USANA Health Sciences has a one year low of $30.51 and a one year high of $87.40. The stock’s 50-day moving average is $79.3 and its 200-day moving average is $64.76. The company has a market cap of $1.093 billion and a price-to-earnings ratio of 14.46.
USANA Health Sciences (NASDAQ:USNA) last announced its earnings results on Tuesday, July 23rd. The company reported $1.72 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.33 by $0.39. The company had revenue of $189.10 million for the quarter, compared to the consensus estimate of $176.60 million. During the same quarter in the prior year, the company posted $1.11 earnings per share. The company’s quarterly revenue was up 17.5% on a year-over-year basis. Analysts expect that USANA Health Sciences will post $5.42 EPS for the current fiscal year.
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.